Dr. William Irving Dorfman, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 224 Commercial Blvd, #303, Lauderdale By The Sea, FL 33308 Phone: 954-817-4864 Fax: 954-204-3725 |
Dr. Roger J Lavine Jr., PSYD. Psychologist - Exercise & Sports Medicare: Not Enrolled in Medicare Practice Location: 222 Commercial Blvd Ste 200, Lauderdale By The Sea, FL 33308 Phone: 954-716-6702 |
Dr. William D Demartini, ED.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 4324 E Tradewinds Ave, Lauderdale By The Sea, FL 33308 Phone: 954-772-6707 |
Dr. Stephen Ronald Levin, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5100 N Ocean Blvd, #1013, Lauderdale By The Sea, FL 33308 Phone: 954-709-7843 |
News Archive
Porter Adventist and Littleton Adventist hospitals have been selected to pilot a new iTriageĀ® feature that allows hospital emergency staff to be further prepared to meet the needs of incoming patients.
An international team of scientists studying acute forms of Leukaemia have identified a new drug target to inhibit the genes which are vital for the growth of diseased cells. The research, reported in EMBO Molecular Medicine, reveals how leukaemia cells become 'addicted' to genes, which if targeted could prevent diseased cells from developing.
The widespread use of a simplified clinical tool to estimate future coronary risk could lead to the classification of millions of Americans into different risk groups than when using the original, "gold-standard" tool. Millions of patients may have been misclassified into higher-risk groups and therefore potentially over-treated, while others may have ended up in lower-risk groups and therefore potentially under-treated for heart disease. The study-, led by William Gordon from Weill Cornell Medical College in the US and colleagues, is published in the Journal of General Internal Medicine-, published by Springer.
In an attempt to recruit many volunteers, the National Institute of Allergy and Infectious Diseases (NIAID) has established a new clinical COVID-19 Prevention Trials Network (COVPN) that aims to enroll thousands of volunteers to test various investigational vaccines against the SARS-CoV-2 infection.
› Verified 5 days ago